THE BRITISH INHERITED METABOLIC DISEASE GROUP

Registered charity 1184024 · accounts filings on the Charity Commission register · also known as BIMDG

To relieve, for the benefit of the public, persons suffering from inherited metabolic disease by advancing the education of professionals involved in their diagnosis, care and treatment; and To promote, for the benefit of the public, research into the treatment of inherited metabolic disease.

Objects

THE OBJECTS OF THE CIO ARE:3.1 TO RELIEVE, FOR THE BENEFIT OF THE PUBLIC, PERSONS SUFFERING FROM INHERITED METABOLIC DISEASE BY ADVANCING THE EDUCATION OF PROFESSIONALS INVOLVED IN THEIR DIAGNOSIS, CARE AND TREATMENT; AND3.2 TO PROMOTE, FOR THE BENEFIT OF THE PUBLIC, RESEARCH INTO THE TREATMENT OF INHERITED METABOLIC DISEASE.

The charity’s charitable objects and area of benefit, quoted from its governing document as held on the Charity Commission register.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£144k
Latest spending
£102k
Registered
2019
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that total income decreased to £144,107 from £169,129 in the prior year, while total expenditure fell more significantly to £101,887 from £176,921. Consequently, unrestricted reserves increased to £101,863, which the Trustees confirm are held to ensure the charity's objectives can be satisfied. The trustees report adequate resources for the foreseeable future, confirming the going concern basis.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Largest income source: symposium income (94% of income)
“symposium income of £134,819” — page 5
Per its FY2025 accounts as filed with the Charity Commission.
Reserves policy: positive reserves exist in an unrestricted fund to ensure that the objectives of the Charity can be satisfied (held: £102k)
“The policy of the Charity is to ensure that positive reserves exist in an unrestricted fund to ensure that the objectives of the Charity can be satisfied.” — page 5
Per its FY2025 accounts as filed with the Charity Commission.

Accounts independently examined (not a full audit). Discloses 5 of 6 completeness components.

Policies the charity declares

In its annual return the charity told the Commission that it has the policies listed below. This is self-declared: it is not verified by the Commission or by this site, and it is not evidence of how a policy works in practice.

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Ireland · Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/12/2025£144k£102k
31/12/2024£13k£21k
31/12/2023£13k£9k
31/12/2022£14k£21k
31/12/2021£12k£6k

Common questions

Is THE BRITISH INHERITED METABOLIC DISEASE GROUP financially healthy?

Per its FY2025 accounts: The accounts state that total income decreased to £144,107 from £169,129 in the prior year, while total expenditure fell more significantly to £101,887 from £176,921. Consequently, unrestricted reserves increased to £101,863, which the Trustees confirm are held to ensure the charity's objectives can be satisfied. The trustees report adequate resources for the foreseeable future, confirming the going concern basis. Its FY2025 accounts were independently examined.